JCCC research seminar featuring Dr. Robert Prins
Personalized immunotherapy approaches for gliboblastoma
- Date: March 16, 2017 12:00 PM - 1:00 PM
- Location: 53-105 CHS
Los Angeles, California 90095
Robert Prins, M.D.
Professor of Neurosurgery and Molecular and Medical Pharmacology
Member, Brain Research Interest
Co-Director, I3T Seminar Series
Dr. Robert Prins' research group studies immune-based therapies for the treatment of malignant glioma. Despite recent advances in traditional treatment options, the prognosis for these patients has not changed appreciably in twenty years. Thus, these patients are left with few treatment options. Members of Prins' research group are attempting to apply what they learn from pre-clinical models towards the implementation of immunotherapy clinical trials for brain tumor patients.
Light lunch served
Sponsored by UCLA's Jonsson Comprehensive Cancer Center Signal Transduction and Therapeutics program